Solid Biosciences
SLDB
SLDB
71 hedge funds and large institutions have $46.9M invested in Solid Biosciences in 2020 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 22 increasing their positions, 22 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.04% less ownership
Funds ownership: 2.88% → 2.84% (-0.04%)
47% less capital invested
Capital invested by funds: $88.5M → $46.9M (-$41.5M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
71
Holding in Top 10
1
Calls
$1.62M
Puts
$782K
Top Buyers
| 1 | +$1.29M | |
| 2 | +$1.19M | |
| 3 | +$389K | |
| 4 |
Two Sigma Advisers
New York
|
+$175K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$122K |
Top Sellers
| 1 | -$2.13M | |
| 2 | -$358K | |
| 3 | -$330K | |
| 4 |
Morgan Stanley
New York
|
-$320K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$288K |